AT209887T - Methods for administration of compositions beneficial to the hair follicles - Google Patents

Methods for administration of compositions beneficial to the hair follicles

Info

Publication number
AT209887T
AT209887T AT94913349T AT94913349T AT209887T AT 209887 T AT209887 T AT 209887T AT 94913349 T AT94913349 T AT 94913349T AT 94913349 T AT94913349 T AT 94913349T AT 209887 T AT209887 T AT 209887T
Authority
AT
Austria
Prior art keywords
administration
methods
hair follicles
compositions beneficial
beneficial
Prior art date
Application number
AT94913349T
Other languages
German (de)
Inventor
Lingna Li
Valeryi K Lishko
Original Assignee
Anticancer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
Priority to US4155393A priority Critical
Priority to US08/181,471 priority patent/US5641508A/en
Application filed by Anticancer Inc filed Critical Anticancer Inc
Priority to PCT/US1994/003634 priority patent/WO1994022468A1/en
Publication of AT209887T publication Critical patent/AT209887T/en
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26718278&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AT209887(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y110/00Oxidoreductases acting on diphenols and related substances as donors (1.10)
    • C12Y110/03Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
    • C12Y110/03001Catechol oxidase (1.10.3.1), i.e. tyrosinase
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/02Cosmetics or similar toilet preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/30Cosmetics or similar toilet preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K8/00Cosmetics or similar toilet preparations
    • A61K8/18Cosmetics or similar toilet preparations characterised by the composition
    • A61K8/72Cosmetics or similar toilet preparations characterised by the composition containing organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/127Liposomes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q5/00Preparations for care of the hair
    • A61Q5/10Preparations for permanently dyeing the hair
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILET PREPARATIONS
    • A61Q7/00Preparations for affecting hair growth
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B82NANOTECHNOLOGY
    • B82YSPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0055Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
    • C12N9/0057Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
    • C12N9/0059Catechol oxidase (1.10.3.1), i.e. tyrosinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004Oxidoreductases (1.)
    • C12N9/0071Oxidoreductases (1.) acting on paired donors with incorporation of molecular oxygen (1.14)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2468Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y114/00Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14)
    • C12Y114/18Oxidoreductases acting on paired donors, with incorporation or reduction of molecular oxygen (1.14) with another compound as one donor, and incorporation of one atom of oxygen (1.14.18)
    • C12Y114/18001Tyrosinase (1.14.18.1)
AT94913349T 1993-04-02 1994-04-01 Methods for administration of compositions beneficial to the hair follicles AT209887T (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
US4155393A true 1993-04-02 1993-04-02
US08/181,471 US5641508A (en) 1994-01-13 1994-01-13 Method for delivering melanin to hair follicles
PCT/US1994/003634 WO1994022468A1 (en) 1993-04-02 1994-04-01 Method for delivering beneficial compositions to hair follicles

Publications (1)

Publication Number Publication Date
AT209887T true AT209887T (en) 2001-12-15

Family

ID=26718278

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94913349T AT209887T (en) 1993-04-02 1994-04-01 Methods for administration of compositions beneficial to the hair follicles

Country Status (8)

Country Link
US (5) US5753263A (en)
EP (1) EP0692972B2 (en)
JP (1) JP2950520B2 (en)
AT (1) AT209887T (en)
AU (1) AU6554594A (en)
CA (1) CA2159626C (en)
DE (2) DE69429337T3 (en)
WO (1) WO1994022468A1 (en)

Families Citing this family (109)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6844326B2 (en) * 1995-06-07 2005-01-18 Anticancer, Inc. Treatment of alopecia
US7556825B2 (en) * 1993-04-02 2009-07-07 Anticancer, Inc. Method for promoting hair growth
AT209887T (en) 1993-04-02 2001-12-15 Anticancer Inc Methods for administration of compositions beneficial to the hair follicles
US6207646B1 (en) * 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US20030026782A1 (en) * 1995-02-07 2003-02-06 Arthur M. Krieg Immunomodulatory oligonucleotides
US5480901A (en) * 1994-10-07 1996-01-02 Zynaxis, Inc. Method for reducing unwanted cellular adhesions
US5756122A (en) * 1995-06-07 1998-05-26 Georgetown University Liposomally encapsulated nucleic acids having high entrapment efficiencies, method of manufacturer and use thereof for transfection of targeted cells
US6261597B1 (en) * 1995-08-31 2001-07-17 Seymour J. Kurtz Method for treating periodontal disease
US6459805B1 (en) 1996-03-26 2002-10-01 Childrens Hospital Los Angeles Fluorescence digital imaging microscopy system
US5766214A (en) * 1996-04-18 1998-06-16 Mehl, Sr.; Thomas L. Melanin enhanced photothermolysis hair removal
WO1997046671A1 (en) * 1996-05-30 1997-12-11 University Of British Columbia Enhanced efficacy of liposomal antisense delivery
US6348450B1 (en) * 1997-08-13 2002-02-19 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom and uses thereof
US20040009936A1 (en) * 1999-05-03 2004-01-15 Tang De-Chu C. Vaccine and drug delivery by topical application of vectors and vector extracts
US6716823B1 (en) 1997-08-13 2004-04-06 The Uab Research Foundation Noninvasive genetic immunization, expression products therefrom, and uses thereof
US6706693B1 (en) 1997-08-13 2004-03-16 The Uab Research Foundation Vaccination by topical application of genetic vectors
US20030045492A1 (en) * 1997-08-13 2003-03-06 Tang De-Chu C. Vaccination by topical application of recombinant vectors
US20030125278A1 (en) * 1997-08-13 2003-07-03 Tang De-Chu C. Immunization of animals by topical applications of a salmonella-based vector
WO1999034831A1 (en) * 1998-01-05 1999-07-15 University Of Washington Enhanced transport using membrane disruptive agents
US6348348B1 (en) 1998-04-07 2002-02-19 The Carnegie Institution Of Washington Human hairless gene and protein
AU753270B2 (en) * 1998-05-21 2002-10-10 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
US6693086B1 (en) * 1998-06-25 2004-02-17 National Jewish Medical And Research Center Systemic immune activation method using nucleic acid-lipid complexes
US20030022854A1 (en) 1998-06-25 2003-01-30 Dow Steven W. Vaccines using nucleic acid-lipid complexes
US20040247662A1 (en) * 1998-06-25 2004-12-09 Dow Steven W. Systemic immune activation method using nucleic acid-lipid complexes
US6372489B1 (en) 1998-10-27 2002-04-16 Anticancer, Inc. Method and model for hair pigmentation
DE69928960T2 (en) * 1998-10-27 2006-08-10 Anticancer Inc., San Diego Preparation of a retrovirus containing the mel locus of Streptomyces, as well as its expression in mammalian cells
FR2791671B1 (en) 1999-04-01 2001-05-11 Oreal New compounds derived from benzoic acid esters, comprising the composition and use
GB9918670D0 (en) 1999-08-06 1999-10-13 Celltech Therapeutics Ltd Biological product
CA2380640A1 (en) 1999-08-18 2001-02-22 Kyowa Hakko Kogyo Co., Ltd. Hair-growing agent
TWI278622B (en) * 1999-10-29 2007-04-11 Shiseido Co Ltd Quantitative hair folliculi absorption method and skin absorption measurement method
AU784884B2 (en) * 1999-12-10 2006-07-20 Anticancer, Inc. Methods for introducing genes into mammalian subjects
US7737108B1 (en) 2000-01-07 2010-06-15 University Of Washington Enhanced transport using membrane disruptive agents
AU2633801A (en) * 2000-01-11 2001-07-24 Clinical Results Inc Dermatological suspensions (micro-matrix)
CA2408152A1 (en) * 2000-05-05 2001-11-15 Wisconsin Alumni Research Foundation Compositions and methods for protecting cells during cancer chemotherapy and radiotherapy
US20040022838A1 (en) * 2001-06-20 2004-02-05 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied peptides
EP1349564A2 (en) * 2000-06-22 2003-10-08 HOLICK, Michael F Regulation of cellproliferation and differentiation using topically applied peptides
WO2002007674A2 (en) * 2000-07-21 2002-01-31 Ceramoptec Industries, Inc. Enhancing compound penetration into hair follicles
US20040013719A1 (en) * 2000-10-06 2004-01-22 Holick Michael F. Regulation of cell proliferation and differentiation using topically applied nucleric acid molecules
US7858117B2 (en) * 2002-02-21 2010-12-28 Novosom Ag Amphoteric liposomes and their use
DE10109897A1 (en) * 2001-02-21 2002-11-07 Novosom Ag Optional cationic liposomes and the use of this
US6984395B2 (en) * 2001-04-11 2006-01-10 Qlt, Inc. Drug delivery system for hydrophobic drugs
WO2002087530A1 (en) * 2001-04-27 2002-11-07 The General Hospital Corporation Tyrosinase assay
US7923431B2 (en) * 2001-12-21 2011-04-12 Ferrosan Medical Devices A/S Haemostatic kit, a method of preparing a haemostatic agent and a method of promoting haemostatis
AU2003233464A1 (en) * 2002-03-29 2003-10-13 Bristol-Myers Squibb Corporation Lipid mediated screening of drug candidates for identification of active compounds
EP1352631A1 (en) * 2002-04-08 2003-10-15 Kao Corporation Hair dye composition
FR2840531B1 (en) * 2002-06-11 2004-10-29 Oreal Cosmetic composition comprising a mimetic of the activity of dopachrome tautomerase (trp-2) to fight against canities
FR2840530B1 (en) * 2002-06-11 2004-12-24 Oreal Cosmetic composition comprising an agent inducing the expression of dopachrome tautomerase (trp-2) to fight against canities
US7585514B2 (en) * 2002-06-11 2009-09-08 L'oreal Administration of agents mimicking DOPAchrome tautomerase (TRP-2) activity for protecting hair follicle melanocytes
JP2006512285A (en) * 2002-06-11 2006-04-13 ロレアル Use and use of drugs mimicking DOPAchrome tautomerase (trp-2) activity as a protective agent for hair follicle melanocytes
JP2006504932A (en) * 2002-09-20 2006-02-09 ザ ジェネラル ホスピタル コーポレーション Methods and compositions for preventing skin damage
JP2006509502A (en) * 2002-12-11 2006-03-23 フェローサン アクティーゼルスカブ Gelatin-based material as a swab
FR2850864B1 (en) * 2003-02-12 2007-04-13 Oreal Use of an inhibitor of 15-hydroxy prostaglandin dehydrogenase for promoting the pigmentation of the skin or the integuments
CA2515440A1 (en) * 2003-02-12 2004-09-02 L'oreal Use of an inhibitor of 15-hydroxyprostaglandin dehydrogenase in order to stimulate pigmentation of the skin or skin appendages
US7326717B2 (en) 2003-05-06 2008-02-05 L'oreal Pyrimidine n-oxide compounds for stimulating the growth of keratin fibers and/or reducing loss thereof
MXPA05012281A (en) * 2003-05-14 2006-05-19 Torreypines Therapeutics Inc Compouds and uses thereof in modulating amyloid beta.
DE10340373A1 (en) * 2003-08-30 2005-03-24 Henkel Kgaa Determining the hair cycle in humans, by measuring protein or mRNA levels and classification as anagenic or catagenic, also for screening therapeutic or cosmetic agents that affect hair growth
US20050058614A1 (en) * 2003-09-15 2005-03-17 Allergan, Inc. Methods for the treatment of gray hair using cyclopentane(ene) heptan(en)oic acid amides
EP2329831A3 (en) 2003-11-05 2011-08-17 Osteoscreen, Inc. Stimulation of hair growth by Ginko biloba flavanoids
US8535711B2 (en) * 2004-01-23 2013-09-17 Teikoku Pharma Usa, Inc. Medication disposal system
US7867511B2 (en) * 2004-01-23 2011-01-11 Travanti Pharma Inc. Abuse potential reduction in abusable substance dosage form
AT475434T (en) * 2004-01-30 2010-08-15 Ferrosan As Hemostatic sprays and compositions
US20050181035A1 (en) * 2004-02-17 2005-08-18 Dow Steven W. Systemic immune activation method using non CpG nucleic acids
US8168600B2 (en) * 2004-04-23 2012-05-01 Isis Pharmaceuticals, Inc. Compositions and methods for topical delivery of oligonucleotides
AU2005238034A1 (en) 2004-04-23 2005-11-10 The Trustees Of Columbia University In The City Of New York Inhibition of hairless protein mRNA
US7706873B2 (en) 2004-05-05 2010-04-27 Mario Ammirati System and method for controlled delivery of a therapeutic agent to a target location within an internal body tissue
DE102004028465A1 (en) * 2004-06-11 2005-12-29 Henkel Kgaa Colorants for keratin fibers
KR20070046093A (en) * 2004-07-09 2007-05-02 훼로산 아크티에 셀스카브 Haemostatic composition comprising hyaluronic acid
US20060073117A1 (en) * 2004-10-01 2006-04-06 Stowers Institute For Medical Research Methods and compositions for controlling hair follicle stem cell fate
KR20080082956A (en) * 2005-09-15 2008-09-12 노보솜 아게 Improvements in or relating to amphoteric liposomes
US7964571B2 (en) 2004-12-09 2011-06-21 Egen, Inc. Combination of immuno gene therapy and chemotherapy for treatment of cancer and hyperproliferative diseases
EP1863511A2 (en) * 2005-02-23 2007-12-12 UAB Research Foundation Alkyl-glycoside enhanced vaccination
KR100617644B1 (en) * 2005-03-24 2006-08-22 메디제네스(주) Compositions for treating alopecia or promoting hair growth
WO2006128084A2 (en) * 2005-05-27 2006-11-30 The Trustees Of Columbia University In The City Of New York Trps1-mediated modulation of hair growth
WO2007109584A1 (en) * 2006-03-16 2007-09-27 University Of Washington Temperature-and ph-responsive polymer compositions
US20080193514A1 (en) * 2006-11-02 2008-08-14 Transcu Ltd. Compostions and methods for iontophoresis delivery of active ingredients through hair follicles
DE102006060154A1 (en) * 2006-12-18 2008-06-19 Henkel Kgaa Methods for molecular characterization of graying and pigmented hair
US7981688B2 (en) 2007-03-08 2011-07-19 University Of Washington Stimuli-responsive magnetic nanoparticles and related methods
ES2583002T3 (en) 2007-04-09 2016-09-16 The Board Of Trustees Of The University Of Arkansas Fusion proteins of a collagen binding domain and parathyroid hormone
FR2918885B1 (en) 2007-07-17 2009-08-28 Oreal Use of extract of bacteria cultivated on thermal water to reduce the pockets and / or periocular rings
US9144546B2 (en) 2007-08-06 2015-09-29 Clsn Laboratories, Inc. Nucleic acid-lipopolymer compositions
FR2920309B1 (en) 2007-08-28 2010-05-28 Galderma Res & Dev Using travoprost to treat hair loss
CA2705714A1 (en) 2007-11-26 2009-06-04 Santaris Pharma A/S Lna antagonists targeting the androgen receptor
AU2011326034B2 (en) 2010-11-12 2016-02-04 Roche Innovation Center Copenhagen A/S Compositions and methods for treating androgen receptor dependent disorders including cancers
JP5569398B2 (en) 2008-02-29 2014-08-13 フェッローサン メディカル ディバイス エー/エス Apparatus for facilitating hemostasis and / or wound healing
FR2928543B1 (en) * 2008-03-17 2013-08-02 Oreal Use of inhibitors of xanthine oxidase for hair pigmentation
FR2928546B1 (en) * 2008-03-17 2013-08-02 Oreal Use of inhibitors of dopa decarboxylase for hair pigmentation.
FR2928545B1 (en) * 2008-03-17 2013-08-02 Oreal Use of monoamine oxidase inhibitors for hair pigmentation
FR2928544A1 (en) * 2008-03-17 2009-09-18 Oreal Use of at least one dopamine beta-hydroxylase inhibitor in a composition or for preparing a composition to enhance the pigmentation of hair and body hair, treat and/or prevent canities and promote regrowth of hair and/or reduce hair loss
FR2929118B1 (en) 2008-03-28 2010-05-07 Oreal Using the combination of madecassoside and / or terminoloside and of arginine for inducing and / or stimulating the growth of these human keratin fibers and / or slow down hair loss
FR2929117B1 (en) 2008-03-28 2010-05-07 Oreal Use of the combination of 2,4-diaminopyrimidine 3-n-oxide and madecassosside and / or terminoloside for inducing and / or stimulating the growth of these human keratin fibers and / or slow down hair loss
US8426214B2 (en) * 2009-06-12 2013-04-23 University Of Washington System and method for magnetically concentrating and detecting biomarkers
US20110117668A1 (en) * 2009-11-09 2011-05-19 University Of Washington Through Its Center For Commercialization Self-powered smart diagnostic devices
US9080933B2 (en) 2009-11-09 2015-07-14 University Of Washington Through Its Center For Commercialization Stimuli-responsive polymer diagnostic assay comprising magnetic nanoparticles and capture conjugates
US9579283B2 (en) 2011-04-28 2017-02-28 Stc.Unm Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery and methods of using same
US9532949B2 (en) * 2011-07-19 2017-01-03 Stc.Unm Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
EP2760412B1 (en) 2011-09-30 2017-07-19 Verde Environmental Technologies, Inc. General medication disposal system
WO2013049380A1 (en) 2011-09-30 2013-04-04 Teikoku Pharma Usa, Inc. Transdermal patch disposal system
WO2013120060A1 (en) 2012-02-09 2013-08-15 The Board Of Trustees Of The University Of Arkansas Delivery of therapeutic agents by a collagen binding protein
EP3391899A1 (en) * 2011-12-14 2018-10-24 The Board of Trustees of the University of Arkansas Delivery of therapeutic agents by a collagen binding protein
JP5906327B2 (en) 2012-01-18 2016-04-20 バイオニア コーポレーションBioneer Corporation Magnetic nanoparticle -SAMiRNA complexes and methods for their preparation
JP6394916B2 (en) 2012-06-12 2018-09-26 フェロサン メディカル デバイシーズ エイ/エス Dry hemostatic composition
WO2014009857A2 (en) * 2012-07-10 2014-01-16 Koninklijke Philips N.V. Release of molecules from container by selective heating of hair
WO2014016118A1 (en) * 2012-07-26 2014-01-30 Unilever N.V. A method of preparing recombinant human tyrosinase
CN105143463A (en) 2013-02-25 2015-12-09 诺华股份有限公司 Novel androgen receptor mutation
RU2016101631A (en) 2013-06-21 2017-07-26 Ферросан Медикал Дивайсиз А/С Extended vacuum dry composition and a syringe to save it
MX2016000020A (en) 2013-07-05 2016-08-18 Bioneer Corp Improved nanoparticle type oligonucleotide structure having high efficiency and method for preparing same.
CN105705639A (en) 2013-07-05 2016-06-22 柏业公司 Dengue virus-specific sirna, double helix oligo-rna structure comprising sirna, and composition for suppressing proliferation of dengue virus comprising rna structure
KR20150006742A (en) * 2013-07-09 2015-01-19 (주)바이오니아 Liver cancer related genes-specific siRNA, double-stranded oligo RNA molecules comprising the siRNA, and composition for the prevention or treatment of cancer comprising the same
US10111980B2 (en) 2013-12-11 2018-10-30 Ferrosan Medical Devices A/S Dry composition comprising an extrusion enhancer
CN106459974A (en) 2014-04-04 2017-02-22 柏业公司 Novel double-stranded oligo rna and pharmaceutical composition comprising same for preventing or treating fibrosis or respiratory diseases

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5147778B2 (en) 1973-12-01 1976-12-16
US4925661A (en) * 1984-04-19 1990-05-15 Leaf Huang Target-specific cytotoxic liposomes
US4957735A (en) * 1984-06-12 1990-09-18 The University Of Tennessee Research Corporation Target-sensitive immunoliposomes- preparation and characterization
US4755388A (en) * 1984-11-09 1988-07-05 The Regents Of The University Of California Liposome-encapsulated 5-fluoropyrimidines and methods for their use
GB8604360D0 (en) * 1986-02-21 1986-03-26 Univ Dundee Stimulation of hair growth
US4806344A (en) 1987-01-05 1989-02-21 Gaskin Frances C Sun protectant composition and method
US4828837A (en) * 1987-03-30 1989-05-09 Liposome Technology, Inc. Non-crystalline minoxidil composition, its production and application
US5290562A (en) * 1987-11-27 1994-03-01 L V M H Recherche Compositions and methods employing liposomes including tyrosine or a tyrosine derivative
FR2628317B1 (en) * 1988-03-09 1991-11-08 Lvmh Rech Composition based on hydrated lipidic lamellar phases or liposomes containing an extract of Scutellaria, or at least one flavonoid such as baicalein or baicalin and cosmetic or pharmaceutical composition, especially dermatological composition, has activity anti-allergic, anti-inflammatory or anti-aging, incorporating
US5077211A (en) * 1988-07-06 1991-12-31 Applied Genetics, Inc. Purification and administration of dna repair enzymes
US5190762A (en) * 1988-07-06 1993-03-02 Applied Genetics, Inc. Method of administering proteins to living skin cells
US5223263A (en) * 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
US5210076A (en) * 1988-09-13 1993-05-11 Berliner David L Methods of treating Parkinson's disease using melanin
IT1231260B (en) * 1988-11-16 1991-11-28 Sergio Bertini Curri Drug and method for increasing volume and speed 'of the capillary microcirculatory flow at the cutaneous level
US5618798A (en) * 1989-04-20 1997-04-08 Bar-Shalom; Daniel Use of sucralfate to treat baldness
FR2648132B1 (en) * 1989-06-08 1991-09-13 Thorel Jean Pigmentogenes compounds, their broadcast vehicles, compositions containing them and their method of preparing
FR2654935B1 (en) * 1989-11-28 1994-07-01 Lvmh Rech Use of xanthines, optionally incorporated into liposomes, for promoting the pigmentation of the skin or hair.
GB9014221D0 (en) * 1990-06-26 1990-08-15 Janssen Pharmaceutica Nv Method of treating alopecia
FR2669225B1 (en) * 1990-11-21 1993-11-12 Lvmh Recherche Gie Using Medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological.
US5723149A (en) * 1990-11-21 1998-03-03 Lvmh Recherche Use of medicago saponins for the preparation of cosmetic or pharmaceutical compositions, especially dermatological compositions, promoting renewal of the epidermis, stimulating hair regrowth or delaying hair loss
DE4113346A1 (en) * 1991-04-24 1992-10-29 Lang Erich Aq. lotion for strengthening and regeneration of hair-growth - comprises ethanol@, phospholipid(s) (derived from soya bean oil) oil, and/or grease
WO1993022773A1 (en) * 1992-05-04 1993-11-11 Berliner David L Process for absorbing ultraviolet radiation using dispersed melanin
US5641509A (en) * 1992-06-26 1997-06-24 Lancaster Group Ag Preparation for topical use
FR2694768B1 (en) * 1992-07-30 1994-12-23 Pasteur Institut oligonucleotide sequences for the specific detection of mollicutes by amplication of conserved genes.
US5302389A (en) * 1992-08-17 1994-04-12 Board Of Regents, The University Of Texas System Method for treating UV-induced suppression of contact hypersensitivity by administration of T4 endonuclease
AT209887T (en) * 1993-04-02 2001-12-15 Anticancer Inc Methods for administration of compositions beneficial to the hair follicles

Also Published As

Publication number Publication date
JPH08511510A (en) 1996-12-03
AU6554594A (en) 1994-10-24
DE69429337T2 (en) 2002-10-10
CA2159626A1 (en) 1994-10-13
US5965157A (en) 1999-10-12
DE69429337D1 (en) 2002-01-17
DE69429337T3 (en) 2012-08-30
WO1994022468A1 (en) 1994-10-13
US6261596B1 (en) 2001-07-17
EP0692972B1 (en) 2001-12-05
EP0692972A1 (en) 1996-01-24
US6224901B1 (en) 2001-05-01
CA2159626C (en) 2001-10-02
EP0692972A4 (en) 1998-05-06
EP0692972B2 (en) 2012-03-21
JP2950520B2 (en) 1999-09-20
US5914126A (en) 1999-06-22
US5753263A (en) 1998-05-19

Similar Documents

Publication Publication Date Title
DE59510954D1 (en) A process for the preparation of pharmaceutical nanosuspensions
DE69409361T2 (en) Preparation of liposomes and methods for substanzverkapselung
DE69527987T2 (en) Formulations and methods for reduction of skin irritation
DE69530212T2 (en) A process for the preparation of organs for cryopreservation
DE69429522T2 (en) Injectable compositions for enlargement of soft tissue
DE69319448T2 (en) Rubber treatment for production of bituminous compositions
DE69530418D1 (en) Formulations and method of reducing skin irritations
DE69307527T2 (en) A process for the preparation of taxane derivatives
DE69512888T2 (en) A process for the preparation of alcohols
DE69325028T2 (en) System for the stabilization of cardiac arrhythmias in real time
DE69327483D1 (en) Diode and methods for preparing
NO303816B1 (en) Aqueous retinoid gel composition
MA22677A1 (en) Cosmetic compositions gels
NO301362B1 (en) Cosmetic moisturizing composition
FI943315A0 (en) The pharmaceutical preparation of effervescent and / or in the form hajoamistabletin or pikarakeiden, as well as the method to prepare them
NO932983L (en) fatty acid Treatment
NO931739D0 (en) Mild skin cleanser toalettsaapestykke
AT246519T (en) Process for production of diagnostic agents
AT161167T (en) Set to the creation of an artificial stomach outset
DE69301022D1 (en) A process for the preparation of block copolymers of conjugated dienes and methyl methacrylates
DE3517385A1 (en) Cosmetic skin cleanser
DE69512841T2 (en) Formulation for disinfection of the skin
DE69308154T2 (en) A process for the preparation of taxane derivatives
DE69429436D1 (en) Cryopreservation of cultured tissue equivalent
DE68928066T2 (en) Process for Acrylamidacylierung of alcohols

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties